MARKET
IPO

ALMR

Alamar Biosciences
ALMR
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-04-17
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-6.59~-5.81
-
-
973.36M~1.10B
-
2026-03-27
Public Filing
View Prospectus
Pending
Offering
Price Range: 15.00~17.00
Shares to be Issued: 9375.00K
2026-04-16
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 64.89M
2026-04-17
Listed
No Data
About ALMR
Alamar Biosciences, Inc. (Alamar Biosciences) is a United States-based precision proteomics company, which is engaged detection and treatment of cancer, and other diseases. The Company is creating sensitive proteomics platform to unmask the deepest secrets of proteome. Alamar Biosciences is automated throughout platform with new biomarker discoveries for early detection and prevention of common diseases.

Webull offers Alamar Biosciences stock information, including NASDAQ: ALMR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALMR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALMR stock methods without spending real money on the virtual paper trading platform.